The optimal surgical management of BRCA-mutation carriers remains a subject of debate. To evaluate the appropriateness of breast cancer (BC) treatment, the oncological outcomes of BRCA-mutation carriers treated either with breast-conserving therapy (BCT) or mastectomy were compared. Additionally, the role of bilateral salpingo-oophorectomy (BSO) and potential independent predictive factors for BC treatment were analyzed.

Surgical management of BRCA-mutation carriers: A single institution experience

Santoro, Armando;Tinterri, Corrado
2022-01-01

Abstract

The optimal surgical management of BRCA-mutation carriers remains a subject of debate. To evaluate the appropriateness of breast cancer (BC) treatment, the oncological outcomes of BRCA-mutation carriers treated either with breast-conserving therapy (BCT) or mastectomy were compared. Additionally, the role of bilateral salpingo-oophorectomy (BSO) and potential independent predictive factors for BC treatment were analyzed.
2022
BRCA
Breast cancer
Breast-conserving therapy
Mastectomy
Salpingo-oophorectomy
File in questo prodotto:
File Dimensione Formato  
surgical.pdf

non disponibili

Descrizione: Articolo in rivista
Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 507.75 kB
Formato Adobe PDF
507.75 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/67742
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 16
social impact